Analyst Ratings for Arcturus Therapeutics (ARCT)
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $68.00 (Laidlaw)
- Lowest: $9.00 (H.C. Wainwright)
- Average: $24.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$24.40 (+136%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$24.40 (+136%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Citi | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
20.00 (8.00) |
14.38 (10.34) |
-28.09% | Details |
| 7/2/2026 | Freedom Broker | N/A | New Coverage | Buy (N/A) |
27.00 (N/A) |
6.89 (10.34) |
50.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
